Through this license Barotech Chambers, used exclusively at Canadian Hyperbarics and Apothec Naturals and Wellness Clinic, are approved for the application of hyperbaric oxygenation on 9 Categories and 21 specific individual indications. Please refer to the tab titled Medical Device Licence. Hyperbaric chambers used at other facilities are only approved for the insured 13 Medical conditions.
Not limited to providing consultation to the Federal Government of Canada, Health Canada, various provincial health authorities and numerous professional Colleges and Associations Gordon's professional expertise has also been extend to the United States Veterans Association, the US Marines and the US Navy. Currently, the United States authorities are providing hyperbaric oxygenation as a primary treatment for veterans with Traumatic Brain Injury and Post Traumatic Stress Disorder.
Gordon Ward sat as the President of the national organization, the Canadian Association of Hyperbarics, a position that he had held since being unanimously voted as the president during the founding of the Association in 1999.
Despite the fact that Hyperbaric Oxygen Therapy is ‘evidence based’ and covered by Alberta Health Care to treat many medical and health conditions, it continues to be a highly ‘political’ and underutilised treatment modality within Canada. Regardless of this, Tami continues to demonstrate his unwavering commitment to the health and welfare of his patients by being a strong advocate and educator regarding Hyperbaric Oxygen Therapies.
Canadian Hyperbarics & Hyperbarics Maple Leaf logo © ALL RIGHTS RESERVED
Regardless of the academic credentials or the professional positions held in hyperbaric therapy, Gordon Ward was and remains the father of a brain injured child. After his son proved that HBO was a viable and valued therapeutic modality for Cerebral Palsy, Hyperbaric Oxygen Therapy became a passion.
Tami Petroski RPN, RN, BScN, DMM, PhD(s)
The Late Gordon Ward’s involvement in hyperbarics is multifaceted.
After seeing the amazing results that Hyperbaric
Oxygen had on the recovery and improved quality-of-life for his
brain injured son he knew that he needed to advocate for others.
Despite the overwhelming evidence supporting Hyperbaric Oxygen
for hypoxic brain injury, the ability to receive HBOT treatment was
a constant battle, often at the mercy of doctors who had very limited
knowledge or ability to prescribe same. Gordon was not immune to
the ‘politics’ surrounding Hyperbarics and he made a bold and
conscious choice to give up a lucrative career to pursue
medical hyperbarics and advocate for others.
Gordon was the Director of Canadian Hyperbarics Ltd. since 1995, during which time he has been responsible for the operation of hyperbaric facilities in Edmonton, Camrose, Red Deer and Calgary. As a hyperbaric facility, Canadian Hyperbarics has provided training and certification in hyperbarics to many qualified persons including MDs, NDs and Registered Nurses.
In 2011 Registered Nurse Tami Petroski began apprenticing with Gordon Ward. She continued her studies earning a Doctorate of Monastic Medicine and a PhD in Indigineous Medicine and soon opened her clinic, Apothec Naturals and Wellness Clinic.
In 2014 Canadian Hyperbarics joined forces with Tami Petroski of Apothec Naturals andWellness Clinic and together they developed extensive wellness Protocols specializing in Cancer and Lyme Wellness. Since the sudden passing of Gordon Ward, Tami Petroski has carried on the work of Canadian hyperbarics.
Their concern about the welfare of their patients and their ability to have access to this very valuable and underutilized medical treatment is truly all consuming. Both Tami and Gordon are consummate researchers. Gordon has authored documents on the therapeutic and technical aspects of hyperbaric chambers, practices and applications.
Working with chamber manufacturer Barotech Inc, Gordon successfully applied to Health Canada for a Medical Device Licence. His application and presented research was received and subsequently approved and licensed by the Federal Government of Canada, through Health Canada, Therapeutic Products Directorate, Medical Devises Bureau under the Medical Device Licence Number 60118.